(redirected from Alpha adrenergic)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Alpha adrenergic: Beta adrenergic
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • noun
  • adj

Synonyms for adrenergic

drug that has the effects of epinephrine

relating to epinephrine (its release or action)

References in periodicals archive ?
These trials confirmed the Company's discovery that, of the three alpha adrenergic receptors, the alpha 1-a receptor is an appropriate target for BPH.
The Global Glaucoma Therapeutics market can be divided into five segments: Prostaglandins, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Fixed Dose Combinations.
When patients were divided into subgroups due to alpha adrenergic blocker treatment, Qmax and Qave values were significantly higher in the sitting position and other parameters did not show any statistically significant difference.
The alpha adrenergic antagonist prazosin has shown promise in multiple case and chart reviews, open-label trials, and placebo-controlled studies.
If this is correct, the standard treatment of using alpha adrenergic agonists may need to be rethought (14).
There are five classes of medications that are considered first-line agents for treatment of hypertension--diuretics beta blockers, alpha adrenergic blockers, calcium channel blockers.
Synaptic Pharmaceutical Corporation (Paramus, NJ; 201-261-1331) announced that it has been awarded a United States patent (6,156,518) for the use of the alpha adrenergic 1B and 1D receptors to screen compounds that bind to them.
The market scenario will change after the launch of new disease-modifying therapies such as NGF binders, transient receptor potential vanilloid (TRPV) antagonists, calcium channel blockers, non-peptide neurotoxins, alpha adrenergic receptors, p38 kinase inhibitors, fatty acid amides hydrolase inhibitors, alpha-2 delta ligands, bradykinin (B2) receptor, N-Methyl-D-aspartate (NMDA) antagonists, sigma 1 agonists and so on.
Phenylephrine is a sympathomimetic agent which acts primarily as an alpha adrenergic agonist.
In March of this year Synaptic began to make available non-exclusive licenses to its alpha adrenergic and benign prostatic hypertrophy patents.
Using ACADIA's functional genomics platform as the foundation for discovery efforts and Allergan's disease models and medicinal chemistry, the companies successfully identified and validated the specific alpha adrenergic gene product that affects intraocular pressure and developed AGN 195795, a gene product specific small molecule drug that selectively activates this gene target.